1. Introduction {#s0005}
===============

In the past few decades, enormous implementation has been made to complete human genome and high throughput genome analysis technologies. However, documentation of specific causative genetic markers could trigger common complex traits *viz.* diabetes, hypertension, CKD *etc.*, which continue to pose a major challenge. Different human genome variations such as single nucleotide polymorphisms (SNPs), microsatellites and variable number of tandem repeats (VNTRs) are used as genetic markers for many diseases ([@bb0365]).

FGF23, CYP24A1 and VDR genes play an important role in the pathogenesis of CKD ([@bb0130], [@bb0360], [@bb0425]), tumoral calcinosis ([@bb0145]) and cancer ([@bb0415], [@bb0390]). FGF23 is the recently discovered regulator of phosphate and mineral metabolism. FGF23 mainly regulates the renal phosphate excretion. FGF23 levels are increased among CKD patients and many cross sectional studies demonstrated that an inverse relationship has been observed in glomerular filtration rate (GFR) with an inverse kidney function ([@bb0265], [@bb0135], [@bb0430]). The increased level of FGF23 leads to the over expression of CYP24A1 mRNA in the kidney ([@bb0025], [@bb0230], [@bb0400], [@bb0185], [@bb0350]). The CYP24A1 enzyme is responsible for the catabolism of 25 hydroxyvitamin D~3~ (25--OHD~3~) and its hormonal form, 1,25-dihydroxyvitamin D~3~(1,25-(OH)~2~D~3~) into 24-hydroxylated products for excretion. The 1,25(OH)~2~D~3~ is the target hormone to induce the VDR expression ([@bb0360]). Further, the active form of the VDR mediates a wide variety of biological actions such as cell proliferation and differentiation, calcium homeostasis, immune modulation, neurological functions and bone mineralization ([@bb0335]). The over-expression of the CYP24A1 leads to VDR dysfunction as it over metabolized the 25OHD~3~ and 1,25(OH)~2~D~3~. Thus, CKD patients ought to experience vitamin D deficiency and subsequent osteoporosis ([@bb0280]). [Fig. 1](#f0005){ref-type="fig"} shows the schematic representation of the disease mechanism.

Discrepancies are observed while establishing the treatment/diagnostic targets for complex multifactorial traits like CKD, hypertension by single locus analysis. This problem is mainly due to the small sample size, varying effects of several disease-predisposing variants, population structure, gene--environment interactions, poor study design or less number of polymorphisms selected for the analysis. These are some of the important factors which can hamper the detection of modest contribution of an individual locus to a trait such as hypertension and CKD. Haplotype based analysis explored different variants segregating at particular loci which will be helpful in studying complex disease. But still it is a daunting task to consider all genetic and non-genetic information in the analytic process. A single nucleotide polymorphism (SNP) is a nucleotide (A, T, G and C) change in the genome, which leads to genetic variation, occurring at each 100--300 bases along the 3-billion-base human genome, even though their density varies between regions ([@bb0140]). A non-synonymous SNP (nsSNP) is known as a single base change in the coding region of a gene. This change leads to the amino acid substitutions (AAS) in the corresponding protein product. If SNP occurs in a primary amino acid sequence, the protein structure and function might be altered, which could lead to drastic phenotype and drug effect changes ([@bb0290]).

Experimental studies are crucial evidence to identify disease associated SNPs from a large number of reported SNPs and to study the functional role of SNPs. Although numerous studies have been carried out on how SNPs are associated with the diseases, it could not be confirmed by subsequent independent studies. In this case, computational analysis could help in saving the time, reducing costs and prioritize SNPs for analysis by quantitative ranking of functionally significant SNPs ([@bb0140]). In this study, we implemented both sequence and sequence-structure-based computational approaches to analyze the SNPs in FGF23, VDR and CYP24A1 genes.

2. Materials and methods {#s0010}
========================

Initially, the SNPs and their related sequences of FGF23, CYP24A1 and VDR genes were retrieved from the National Center for Biotechnology Information (NCBI) database of SNPs, dbSNP (<http://www.ncbi.nlm.nih.gov./SNP/>) for our computational analysis. We strict our list to missense mutation, that is mainly associated with the diseases ([@bb0045], [@bb0300]).

Sequence based and structure based methods are the two common approaches used in SNP prediction tools. Compared to the structure based predictions, sequence-structure based predictions are more precise one, since it includes all types of effect at the protein level, and can be applied to any human protein with known relatives ([@bb0465], [@bb0305], [@bb0405]). Sequence based predictions are failed to explain the underlying mechanism of how the single nucleotide polymorphism will alter the protein phenotype, whereas the structure based approaches may solve this limitation. Thus, we used the combination of structure based and sequence based approaches to validate the different aspects of SNP analysis ([@bb0460], [@bb0405]).

3. Sequence based tools {#s0015}
=======================

3.1. SIFT {#s0020}
---------

The human nsSNP which is available in dbSNP was analyzed by sorting intolerance from tolerant (<http://sift.jcvi.org/www/SIFT_dbSNP.html>). The difference between functional and non-functional SNPs in coding regions was predicted by SIFT. The results from this software helped to predict the substitutions of an amino acid on phenotypic effect. SIFT predictions are mainly based on physiochemical properties of amino acid and sequence homology ([@bb0320]).

The SIFT algorithm uses a modified version of PSI Blast ([@bb0015]) from NCBI ([@bb0435]) and Dirichlet mixture regulation ([@bb0410]) in order to construct multiple sequence alignment of protein sequences. It aligned the query sequences globally and all the sequences which are in same clad. The SIFT scores \> 0.05 are considered by the algorithm to be tolerant ([@bb0395]).

3.2. SNP & GO {#s0025}
-------------

The SNPs which are likely to be involved in the pathogenesis of human disease might be predicted by the SNP & GO server. It predicts the disease related mutations from a protein sequence and the functional annotation of the protein on the basis of support vector machines (SVMs).

The SNP & GO server collected the information from different sources such as protein sequence, the local sequence environment of the SNPs, the protein sequence profile, features generated from sequence alignment, and protein function. This server annotated the information from the gene ontology database (GO). This database included the gene products in terms of their associated biological processes, cellular components and molecular functions ([@bb0050]).

4. Combined sequence and structure based prediction tools {#s0030}
=========================================================

4.1. PolyPhen-2 {#s0035}
---------------

The possible impact of an amino acid on the structure and function of a human protein was predicted by polymorphism phenotyping V2 (<http://genetics.bwh.harvard.edu/pph2/>) using physical and comparative considerations. The results from the PolyPhen-2 output encompass a score that ranges from 0 to a positive number. The zero indicates the neutral effect of SNP on protein structure whereas the large positive number indicates the substitution that may have severe effects ([@bb0380], [@bb0445], [@bb0325]).

4.2. I-Mutant {#s0040}
-------------

Protein stability changes upon single-site mutations were calculated by a neural-network-based web-server I-Mutant. The tool generated an output in connection with dataset derived from ProTherm ([@bb0035]). I-Mutant predicted the protein mutation which stabilizes or destabilizes the protein structure. The free energy value was also computed with the energy-based FOLD-X tool. The reliability index value was calculated by coupling the FOLD-X predictions with I-Mutant ([@bb0160]).

5. Computational site directed mutagenesis {#s0045}
==========================================

The human CYP24A1 protein crystal structure was not solved, but the rat CYP24A1 crystal structure was available in the protein data bank (PDB) ([@bb0040]) (PDB id: [3K9V](pdb:3K9V){#ir0145}) ([@bb0020]). The sequence similarity between both the sequences was 85%. Thus we modeled the human CYP24A1 protein using rat CYP24A1 in Prime module of Schrodinger software ([@bb0370]). The FGF23 (PDB id: [2p39](pdb:2p39){#ir0150}) ([@bb0155]) and VDR (PDB id: [3B0T](pdb:3B0T){#ir0155}) ([@bb0220]) crystal structures were downloaded from the PDB. Computational mutagenesis was performed using [@bb0285]. After mutagenesis, each protein was optimized and energy minimized using OPLS_2005 force field in the protein preparation wizard of Schrodinger, LLC. After energy minimization, the mutant structure was superimposed with the corresponding native structure and the root mean square deviation (RMSD) was calculated. The RMSD is the square root of the mean of the square of the distance between the matched atoms.$$\text{RMSD} = \text{SQRT}\ \left\lbrack \left\{ {{SUM}\ \left( d_{ii} \right)^{2}} \right\}/N \right\rbrack$$where d~ii~ is the distance between the ith atom of structure l and ith atom of structure 2 and N is the number of atoms matched in each structure.

6. Analysis of effect of mutation on protein solvent assessable area and secondary structure {#s0050}
============================================================================================

The accessible surface area (ASA) was calculated by rolling a sphere size of a water molecule over the protein space which was accessible to a solvent ([@bb0085]). The ASA was mostly transformed to the relative surface area (RSA) for the comparative and predictive purpose. It was calculated to the given amino acid residue in the polypeptide chain, relative to the maximum possible exposure of the residue in the center of a tri-peptide flanked with either glycine ([@bb0120]) or alanine ([@bb0090]). Understanding the degree of surface exposure of an amino acid was valuable since it was used to enhance the understanding of a variety of biological problems such as protein--ligand interactions ([@bb0010]) and protein--protein interactions ([@bb0210], [@bb0215]), active sites ([@bb0170]), and structural epitopes ([@bb0210], [@bb0215]) and the prediction of disease related SNPs ([@bb0345]). The RSA can be calculated as follows,$${RSA} = \frac{ASA}{{ASA}_{\max}}$$where ASA~max~ is the maximum obtained solvent exposed area ([@bb0355]).

In order to compare the surface accessibility, from exposed to buried regions were calculated. Geneious Pro ([@bb0225]) software (Aukland, New Zealand) was used to compare the secondary structure of the wild and mutant type of the protein. The pI for protein folding and unfolding free energy, optimum pH for protein stability was further calculated using PROKA 3.0 (Copenhagen, Denmark) ([@bb0235], [@bb0340]).

7. Statistical analyses {#s0055}
=======================

In statistical prediction the following three cross-validation methods are often used to evaluate the anticipated success rate of a predictor: independent dataset test, sub-sampling (or K-fold cross-validation) test, and jackknife test ([@bb0115]). Among the three, however, the jackknife test is deemed the least arbitrary and most objective as elucidated by Eqs. 28--32 of [@bb0095]. Therefore, the jackknife test has been widely recognized and increasingly used to test the quality for various predictors ([@bb0080], [@bb0065], [@bb0070], [@bb0055], [@bb0060], [@bb0240], [@bb0245], [@bb0260], [@bb0270], [@bb0255], [@bb0275], [@bb0375], [@bb0195], [@bb0200]).

Six different parameters were widely used to describe the predictions quality *viz.* accuracy, precision, sensitivity, specificity, negative predictive value (NPV) and Matthews correlation coefficient (MCC). In the following equations true positives, true negatives, false positives and false negatives are represented as *tp*, *tn*, *fp* and *fn* respectively.$$\text{Accuracy} = \frac{\mathit{tp} + \mathit{tn}}{\mathit{tp} + \mathit{tn} + \mathit{fp} + \mathit{fn}}$$$$\text{Specificity} = \frac{\mathit{tn}}{\mathit{fp} + \mathit{tn}}$$$$\text{Sensitivity} = \frac{\mathit{tp}}{\mathit{tp} + \mathit{fn}}$$$${MCC} = \frac{\mathit{tp} \times \mathit{tn} - \mathit{fn} \times \mathit{fp}}{\sqrt{\left( {\mathit{tp} + \mathit{fn}} \right)\left( {\mathit{tp} + \mathit{fp}} \right)\left( {\mathit{tn} + \mathit{fn}} \right)\left( {\mathit{tn} + \mathit{fp}} \right)}}.$$

Unfortunately, the four metrics formulated in Eqs. [(3)](#fo0015){ref-type="disp-formula"}, [(4)](#fo0020){ref-type="disp-formula"}, [(5)](#fo0025){ref-type="disp-formula"}, [(6)](#fo0030){ref-type="disp-formula"}, are not intuitive and easy-to-understand to most biologists especially the equation for MCC. Hence, we adopted the formulation proposed by [@bb0110]. According to the formulation, the same four metrics can be expressed as$$\text{Accuracy} = 1 - \frac{N_{-}^{+} + N_{+}^{-}}{N^{+} + N^{-}}$$$$\text{Sensitivity} = 1 - \frac{N_{-}^{+}}{N^{+}}$$$$\text{Specificity} = 1 - \frac{N_{+}^{-}}{N^{-}}$$$${MCC} = \frac{1 - \left( {\frac{N_{-}^{+}}{N^{+}} + \frac{N_{+}^{-}}{N^{-}}} \right)}{\sqrt{\left( {1 + \frac{N_{+}^{-} - N_{-}^{+}}{N^{+}}} \right)\left( 1 + \left( \frac{N_{-}^{+} + N_{+}^{-}}{N^{-}} \right) \right.}}$$where N^+^ is the total number of SNPs investigated, whereas *N* ~−~ ^+^ is the number of the disease caused by SNPs which were incorrectly predicted as neutral; N^−^ is the total number of non-synonymous SNPs investigated, and *N* ~+~ ^−^ is the number of the non-synonymous SNPs wrongly predicted as deleterious.

The MCC ([@bb0295]) is a good evaluation statistics, because it was unaffected by the different proportions of neutral and pathogenic datasets predicted by different programs. Overall the MCC was insensitive to different test set sizes and thus it gives a more balanced assessment of performance than the other performance measures ([@bb0030]). The use of these metrics and their merits has been concurred by a series of recent studies ([@bb0055], [@bb0060], [@bb0195], [@bb0200], [@bb0255], [@bb0275]). The set of metrics is valid only for the single-label systems. For the multi-label systems whose existence has become more frequent in system biology ([@bb0110]) and system medicine ([@bb0450]), a completely different set of metrics as defined by [@bb0100] is needed.

8. Results {#s0060}
==========

The main objective of the present study is to identify the pathogenic SNPs from the pool of SNPs reported in NCBI using the web based analysis tools. We have used both the combined sequence and sequence-structure-based tools in order to overcome the limitations of both the methods towards the prediction of risky SNPs associated with CKD. The workflow followed in this study is shown in [Fig. 2](#f0010){ref-type="fig"}.

[@bb0420] had reported the accuracy of SNP & GO (0.82) and that it is comparably good with PolyPhen 2 (0.69) and SIFT (0.65). The SNP & GO software predicted a high precision value (0.90) in comparison to PolyPhen-2 (0.71), SIFT (0.64). SNP & GO, SIFT, PolyPhen-2, and I-Mutant software were used to analyze all our dataset including SNPs from the Uniprot disease database (664 SNPs) and 287 non-sense mutations.

9. Statistical analysis of the performance from *in silico* prediction methods {#s0065}
==============================================================================

We used six different statistical measures, namely accuracy, precision, specificity, sensitivity, negative predictive value (NPV), and Matthews correlation coefficient (MCC) to evaluate the performance of the tools. Initially a dataset comprising of deleterious SNPs from Uniprot disease database and nsSNPs was formed and we predicted the performance of the tools. Based on the computational method predictions, the dataset was evaluated to obtain *tp* (true positive), *tn* (true negative), *fp* (false positive) and *fn* (false negative) values in order to calculate the statistics measures ([Table 1](#t0005){ref-type="table"}). Based on the statistical analyses, I-Mutant (0.89) and SNP & GO (0.72) performed well in terms of accuracy, I-Mutant (0.91) and SIFT (0.85) performed well in terms of precision, SIFT (0.72) and PolyPhen-2 (0.61) performed well in terms of specificity and I-Mutant (0.97) and SNP & GO (0.89) performed well in terms of sensitivity and SNP & GO (0.75) and PolyPhen-2 (0.75) performed good in terms of NPV and PolyPhen-2 (0.42) performed well in terms of MCC. Overall the accuracy predictions were worst in the case of SIFT tool (0.71) and PolyPhen-2 (0.71), PolyPhen-2 performed worst in terms of precision (0.67), I-Mutant and SIFT performed worst in terms of specificity (0.32) and sensitivity (0.71) respectively. Further, we performed the statistical analysis for the combined sequence based and sequence-structure based prediction methods. Interestingly, our findings clearly exhibit that the predictions based on both sequence and sequence-structure based method produced good statistical method (MCC = 0.45) rather than single individual method.

10. SNP dataset {#s0070}
===============

FGF23, CYP24A1 and VDR genes play a very important role in the CKD pathogenesis, which were selected for computational analysis of deleterious SNPs. We have selected SNPs only from the coding regions, since coding regions are critical for the determination of protein tertiary structure and function.

11. Prediction of deleterious nsSNPs using sequence based prediction tools {#s0075}
==========================================================================

In the initial process, we analyzed all the SNPs with sequence based prediction tools. SIFT algorithm was used for the protein conversion and predicted whether an amino acid substitution had an impact on protein function by aligning similar proteins. Further, a score was generated to determine the evolutionary conversion status of the amino acid of interest. The retrieved 739 SNPs were submitted to the SIFT program to check its tolerance and 454 SNPs have found to be having missense mutation in the coding region.

The output scores for the SIFT analysis ranges from 0 to 1, while 0 represents damaging whereas 1 denotes neutral. If the SIFT cutoff score is lower than the 0.05, the amino acid change at a particular position is tolerated (no effect). Further, the repetitive amino acid substitutions would be predicted as deleterious. The SIFT algorithm predicted 4 SNPs from FGF23 gene, 15 SNPs from VDR gene and 13 SNPs from CYP24A1 gene which were found to be having a critical deleterious role ([Table 2](#t0010){ref-type="table"}).

The SNP & GO tool is a collection of unique framework, and includes information derived from protein sequence, and evolutionary information and function as encoded in the Gene Ontology terms. The software predicts the human disease related SNPs in proteins with functional annotations. 12 SNPs from FGF23 gene, 60 SNPs from VDR gene and 22 SNPs from CYP24A1 gene were predicted to be associated with human diseases ([Table 2](#t0010){ref-type="table"}).

12. Prediction of deleterious nsSNPs using sequence-structure based prediction tool {#s0080}
===================================================================================

The PolyPhen-2 program was used to determine the structural level alterations. Various parameters such as evolutionary conservation, physicochemical differences and the proximity of the substitution were considered in order to predict functional domains, and structural features and functional effects of amino acid changes. PolyPhen-2 score in the dataset ranges from 0 to 1. If the PolyPhen-2 score is \< 0.5 then the mutation is a benign one. The changes are possibly damaging if the score is \> 0.5 and \> 0.9 are probably damaging. 13 SNPs from FGF23 gene, 45 SNPs from VDR gene and 62 SNPs from CYP24A1 gene were predicted to be probably/possibly damaging and these SNPs may affect the structural stability and the phenotype of the protein ([Table 2](#t0010){ref-type="table"}).

I-Mutant program was used to check the stability of the protein caused by nsSNPs. This program calculated the energy difference between native and variant proteins based on Gibbs free energy values. I-Mutant predictions were classified into three different classes *viz.* neutral mutations (− 0.5 ≤ kcal/mol), mutations which decreased the Gibbs free energy (− 0.5 \< kcal/mol), and mutations which produce a larger increased energy (0.5 \> kcal/mol). 21 SNPs from FGF23 gene, 174 SNPs from VDR gene and 83 SNPs from CYP24A1 gene might decrease the protein stability ([Table 2](#t0010){ref-type="table"}).

The wild type protein was mutated using [@bb0285]. Further, the mutated protein was optimized and energy minimized using protein preparation wizard, [@bb0285]. The RMSD between the wild type and mutant type was calculated and reported in the [Table 2](#t0010){ref-type="table"}.

We adopted four online SNP prediction tools (two sequence based and two sequence-structure based) to reduce the false positive errors. These online servers were used for different parameters such as sequence, evolutionary approach, physicochemical, secondary structure, solvent accessibility, and free energy calculations for analysis. After analysis, all the results predicted by four different SNP prediction servers, we anticipated that those SNPs which were predicted to be disease/disorder/damaging *etc.*, by at least three different algorithms, had high RMSD and may show functional significance and it may be the reason behind the cause of disorder to the human body ([Table 1](#t0005){ref-type="table"}). Such SNPs are listed below: *FGF23* rs104894342 (S71G), rs104894343 (M96T), rs104894344 (S129F), rs575204793 (R160Q); SNP id\'s of *VDR* rs121909796 (R274L), rs121909799 (I314S), rs121909800 (R391C), rs121909802 (E329K), rs11574090 (L230V), rs75590999 (I367M), rs114678556 (R358H), rs199705103 (R154W); SNP id\'s of *CYP24A1* rs6068812 (L409S), rs114368325 (R396W), rs387907322 (R159Q), rs387907324 (E322K), rs58713852 (T248K), rs114476330 (R120H), rs114579367 (D202H), rs116548533 (R344H), rs139763321 (L148P), rs140189382 (Y407N), rs141152573 (R439H), rs143934667 (R396Q), rs146980218 (R439Q). [Fig. 3](#f0015){ref-type="fig"} shows the superimposed structure of wild and mutant proteins.

Additionally, the solvent accessible areas of 25 deleterious SNPs were analyzed to better understand the relationship between sequence and structure. Thus the solvent accessible area was calculated by NetsurfP server (Kongens Lyngby, Denmark). NetSurfP predicted the amino acids, whether in exposed region or buried region at 25% threshold (residues may be predicted to be exposed/buried based on a 25% threshold). The changes in exposed to buried or buried to expose regions due to mutation were shown in [Table 3](#t0015){ref-type="table"}. Mutations in the buried sites are more prone to disrupt the protein structure compared to mutations introduced in the solvent exposed structures. Thus, the latter tend to destabilize proteins, through steric hindrance and the introduction of strained conformations. Mutation in FGF23 and VDR genes shows the number of changes from buried to expose and exposed to buried when compared to CYP24A1 gene.

13. Relative surface area {#s0085}
=========================

The analysis of the RSA and ASA of the wild type and mutant type for all the residues is shown in [Fig. 4](#f0020){ref-type="fig"}, [Fig. 5](#f0025){ref-type="fig"}. After analyzing the graph it was found that the FGF23 and VDR have changes in their RSA and ASA value of the wild type except CYP24A1. In FGF23, Q54K SNP produced slight different RSA and ASA when compared to the wild type. The same type of slight difference was observed in the CYP24A1:I367M SNP. The effect of SNP in the formation of secondary structure was analyzed and displayed in the [Fig. 6](#f0030){ref-type="fig"}.

In FGF23, a small deletion of alpha helix was observed in S71G mutation. In M96T, one extra turn was noticed near the helical region. Moreover, the addition of an extend beta strand was observed in FGF23--S129F SNP. Finally, in R160Q the coil was extended towards its right side.

In VDR, L230V SNP led to small changes in the beta strand. In R274L mutation, the small beta strand coil changed and instead a long alpha helix was formed. The E329K formed a linear alpha helix. In R358H, the small turn was changed into a coil. The remaining SNPs could not cause significant changes in the secondary structure.

In CYP24A1, R120H led to a change into turn. L148P mutation brought about change in the formation of small coil structure. An extension of alpha helix was observed in the T248K mutation. Further, in L409S mutation a coil is presented instead of alpha helix. The remaining mutations could not cause significant change in the protein secondary structure.

Further, we analyzed the pH for optimum stability, pI for folding and unfolding are free energy of the wild and mutant protein and found that all the three proteins were stable at different pH. FGF23 was stable at 9.6 pH, VDR was stable at 7.8 to 8.5 pH and CYP24A1 was stable at 7.9 to 8.6 pH. There were no vigorous changes observed in the optimum pH of wild and mutant proteins. The CYP24A1 enzyme had more binding energy when compared to the remaining two proteins. The predicted pH value is shown in [Table 4](#t0020){ref-type="table"}.

14. Discussion {#s0090}
==============

Identification of the disease causing mutations from those which are functionally neutral is very essential to understand the molecular pathophysiology of the diseases. In recent days, amino acid substitutions account for approximately half of the known gene lesions responsible for human inherited disease ([@bb0125]). Thus, identification of nsSNPs which affect protein functions and causing disease is crucial. In natural selection, many of the nsSNPs effects are neutral since mutations are removed in essential positions. Therefore, researchers have the ability to discriminate accurately significant, protein function altering SNPs from those that are functionally neutral ([@bb0045]). However, there is increasing evidence of availability for the role of coding or non-coding mutations in protein regulatory functions and subsequent diseases ([@bb0455], [@bb0180]). Analyzing the vast number of SNPs might not be reasonable for researchers to carry out *in vitro* experiments on each and every SNP to infer from their biological significance. Thus, the vast number of SNPs causes challenge to biologists as well as bioinformaticians. Apart from these, numerous studies are in progress to study the effect of SNPs in genetic profiles and alteration pharmacogenomic drug profiles using a molecular epidemiological approach.

In this paper, we attempted to predict the SNPs which can alter the protein expression and function in three interlinked genes (FGF23, VDR and CYP24A1). The mutations among these genes have associated with several diseases ([@bb0025], [@bb0400], [@bb0265], [@bb0350], [@bb0135]).

Thus, the changes of amino acids in particular region might be associated with several diseases. Therefore, our study would pave way in selecting SNPs that were likely to have potential complexity to refine SNP prediction. GO based score was incorporated in the SNP & GO prediction algorithm which enables correlation between given SNP and its corresponding gene product function. PANTHER predicted classification data that is also included in the SNP & GO prediction. SNP & GO tool was more advanced than PANTHER. As PANTHER requires Gene or dbSNP IDs which cannot be entered directly as search inputs, limiting the scope of searches to the protein sequence level and require information on protein alignment for search input. PolyPhen-2 ranking of the SNPs on the basis of protein phenotype changes which caused by severe SNP effects. I-Mutant server uses a neural network based web server for the analysis of the protein stability upon the single mutation.

Out of 740 missense SNPs reported in dbSNP, we found 25 missense SNPs in the coding region which may affect the normal gene regulation or protein stability. Mutation in FGF23 gene was associated with hyper and hypo phosphatemia ([@bb0165], [@bb0385]), familial tumoral calcinosis ([@bb0145]) and autosomal dominant hyophosphatemic rickets ([@bb0005]) *etc.* Five mutations (H41Q, S71G, M96T, S129F, and Q54K) in the coding region were already reported ([@bb0150]). Interestingly, in our *in silico* findings, we also found that these five mutations have a significant effect on protein structure and stability. Consistent with *in vitro* findings, we hypothesized that the mutations in these regions lead to alter in peptide folding and decreased in FGF23 secretion. Moreover, we predicted that the protein stability was decreased with respect to these mutations.

CYP24A1 gene mutations were known to cause hypercalcemia, nephrocalcinosis and nephrolithiasis *etc.* R159Q mutation in the coding region disrupts the hydrogen bond interaction in the CYP24A1 active site ([@bb0190]). Thus, this SNP analysis also revealed that mutation decreased the protein structure stability. L409S mutation affected the enzyme activity since it leads to weakening the binding with 1,25(OH)~2~D~3~ ([@bb0315]). In secondary structure analysis, we found that the alpha helix was changed into beta turn and might be a structural change to cause this effect. Moreover, the enzyme activity decreased in L148P mutation because of the direct interaction with enzyme substrate ~(~[@bb0315]), therefore, this mutation leads to decrease in enzyme activity. Small coil was changed in this particular region and may cause the protein stability and activity.

VDR has long been known for its important role in regulating body levels of calcium (Ca) and phosphorous (P) and in mineralization of bone ([@bb0175]). In VDR gene, we found eight polymorphisms as more deleterious. VDR mutations were associated with rickets, cancer, osteoporosis *etc.* VDR activation is essential for different types of cellular processes. R274L mutation in the active site region causes changes in VDR structure between helices H1 & H2 ([@bb0310]). Secondary structure analysis predicted the deletion of beta strand and coil formation of alpha helix. Moreover, I314S ([@bb0440]) and R391C ([@bb0330]) mutation was found to have changed the conformations and leads to changes in hormonal binding domain. Among these, R391C mutation was well known for its ability to reduce the binding with steroid receptor co-activator 1 (SRC-1). Interestingly, our *in silico* findings elucidate the deleterious nature of these polymorphisms. Therefore, our findings conceal that these mutations may affect the gene expression and the protein structure.

To the best of our knowledge, no comprehensive evaluation of the performance of missense variant pathogenicity predictors has been made outside the performance studies of individual methods in the context of identification of SNPs associated with risk. We selected test sets which have not been used in the training set of all methods, but the pathogenic subset was comprised of dataset from Uniprot disease database mutations. Testing the performance of a method with the same cases when it was trained would lead to biased results, thus data set from Uniprot disease database mutations would have an advantage over the other methods. The performance decreased in all methods regardless whether trained on Uniprot data or not. But, if we combined the sequence based and sequence-structure based results it outperforms than the individual methods.

The neutral dataset was generated from dbSNP entries that had \> 1% frequency when there was data at least for 25 individuals (50 chromosomes). By this way we minimized the number of false negatives in the test set.

Out of 25 deleterious SNP reports from our study, 8 SNPs were already reported in the Uniprot disease database. Different parameters such as sequence, evolutionary approach, physiochemical, secondary structure, solvent accessibility, and free energy calculations were used for the analysis of SNPs.

As demonstrated in a series of recent publications ([@bb0055], [@bb0195], [@bb0200], [@bb0205], [@bb0255], [@bb0275], [@bb0250]) in developing new prediction methods, user-friendly and publicly accessible web-servers will significantly enhance their impacts ([@bb0105], [@bb0075]), we shall make efforts in our future work to provide a web-server for the prediction methods presented in this paper.

15. Conclusion {#s0095}
==============

In the present study, we investigated the functional and structural impact of SNPs caused by the CKD associated genes (FGF23, CYP24A1 and VDR) using different computational prediction tools. The approach can also be applied to study the relationship between SNP conservation levels and epidemiological studies among these studied genes. 25 SNPs were predicted to be disorder/diseases/damaging *etc.*, by three or four different algorithms and high RMSD will show functional significance and it may cause disorder in the human body. Out of which four SNPs (S71G, M96T, S129F, R160Q) of FGF23 gene, eight SNPs (R274L, I314S, R391C, E329K, L230V, I367M, R358H, R154W) of VDR gene and thirteen SNPs (L409S, R396W, R159Q, E322K, T248K, R120H, D202H, R344H, L148P, Y407N, R439H, R396Q, R439Q) of CYP24A1 gene were found to have a possible functional effect in the coding region of our comparative sequence and structure--SNP based analysis tools with low RMSD value. Further, experimental study needs to be carried out for further validation to analyze the functional effect of the mutations reported in the [Table 1](#t0005){ref-type="table"}. As we mentioned earlier, our combined sequence and sequence-structure based methods outperformed than the available methods. Thus, our method is the best one for prioritizing nsSNPs out of SNP pool.

The *in silico* data presented here demonstrate the comparative computational approach for classification of three difference gene variants which is a powerful and fast technique and can be used for large scale analyses. The present study will also be helpful to understand the functional variation from the perspective of structure, expression, evolution, physiochemical property, and phenotypes and can help the experimental geneticists to carry out their large scale SNP analysis.
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![Superimposed structure of wild type FGF23 and S71G mutant (A), wild type of VDR and R274L mutant (B), wild type CYP24A1 and L409S mutant. The SNPs in this figure are randomly selected from each gene for the easy interpretation of the result.](gr3){#f0015}

![The relative surface area (RSA) of wild type and selected mutant type of FGF23 gene (A), CYP24A1 gene (B) and VDR gene (C).](gr4){#f0020}

![The accessible surface area (ASA) of wild type and selected mutant type of FGF23 gene (A), CYP24A1 gene (B) and VDR gene (C).](gr5){#f0025}

![Multiple sequence alignment and secondary structure prediction of FGF23, CYP24A1 and VDR genes. Alignment of secondary structure identified the β--strand to alpha change in S71G mutant, β--strand to turn change in M96T mutant, addition of β--strand in S129F mutant, addition of coil in R160Q mutant (A), addition of β--strand in L230V mutant, addition of alpha helix in R274L and E329K mutants, turn to coil change in R385H mutant (B), Turn to coil change in R120H mutant, β--strand to coil change in L148P mutant, coil to β--strand mutant in T248K mutant and alpha helix to β--strand and turn change in L409S mutant.](gr6){#f0030}

###### 

Statistical evaluation of various computational methods.

Table 1

                SIFT   SNP & GO   PolyPhen-2   I-Mutant   Combined sequence and sequence-structure based method
  ------------- ------ ---------- ------------ ---------- -------------------------------------------------------
  Tp            270    286        164          553        1273
  Tn            123    110        126          25         384
  Fp            48     117        80           52         297
  Fn            110    36         40           16         202
  Cases +       380    322        204          569        1475
  Cases −       171    227        206          77         681
  Accuracy      0.71   0.72       0.71         0.89       0.77
  Specificity   0.72   0.48       0.61         0.32       0.56
  Sensitivity   0.71   0.89       0.80         0.97       0.86
  MCC           0.40   0.41       0.42         0.39       0.45

###### 

Analysis of SNPs detected in the coding region of FGF23, VDR and CYP24A1 genes.

Table 2

                                        SIFT                                  I-Mutant      SNP & GO    PolyPhen-2   RMSD (Å)                                           
  ------------------------------------- ------------------------------------- ------------- ----------- ------------ ---------- ------------------- ------------------- ------
  FGF23                                 [Q9GZV9](uniprotkb:Q9GZV9){#ir0005}   rs104894342   S71G        Damaging     Decrease   Disease             Probably damaging   5.72
  [Q9GZV9](uniprotkb:Q9GZV9){#ir0010}   rs104894343                           M96T          Damaging    Decrease     Disease    Probably damaging   6.66                
  [Q9GZV9](uniprotkb:Q9GZV9){#ir0015}   rs104894344                           S129F         Damaging    Increase     Disease    Probably damaging   5.77                
  [Q9GZV9](uniprotkb:Q9GZV9){#ir0020}   rs575204793                           R160Q         Damaging    Decrease     Disease    Possibly damaging   5.77                
  VDR                                   [P11473](uniprotkb:P11473){#ir0025}   rs121909796   R274L       Damaging     Decrease   Disease             Possibly damaging   7.85
  [P11473](uniprotkb:P11473){#ir0030}   rs121909799                           I314S         Damaging    Decrease     Disease    Benign              6.87                
  [P11473](uniprotkb:P11473){#ir0035}   rs121909800                           R391C         Damaging    Decrease     Disease    Probably damaging   6.83                
  [P11473](uniprotkb:P11473){#ir0040}   rs121909802                           E329K         Damaging    Decrease     Disease    Probably damaging   7.70                
  [P11473](uniprotkb:P11473){#ir0045}   rs11574090                            L230V         Damaging    Decrease     Disease    Possibly damaging   8.13                
  [P11473](uniprotkb:P11473){#ir0050}   rs75590999                            I367M         Damaging    Decrease     Disease    Probably damaging   7.19                
  [P11473](uniprotkb:P11473){#ir0055}   rs114678556                           R358H         Tolerated   Decrease     Disease    Possibly damaging   7.14                
  [P11473](uniprotkb:P11473){#ir0060}   rs199705103                           R154W         Damaging    Decrease     Disease    Probably damaging   8.63                
  CYP24A1                               [Q07973](uniprotkb:Q07973){#ir0065}   rs6068812     L409S       Damaging     Decrease   Disease             Probably damaging   3.51
  [Q07973](uniprotkb:Q07973){#ir0070}   rs114368325                           R396W         Damaging    Decrease     Disease    Probably damaging   3.08                
  [Q07973](uniprotkb:Q07973){#ir0075}   rs387907322                           R159Q         Damaging    Decrease     Disease    Probably damaging   4.92                
  [Q07973](uniprotkb:Q07973){#ir0080}   rs387907324                           E322K         Damaging    Decrease     Disease    Probably damaging   3.61                
  [Q07973](uniprotkb:Q07973){#ir0085}   rs58713852                            T248K         Damaging    Decrease     Disease    Probably damaging   4.04                
  [Q07973](uniprotkb:Q07973){#ir0090}   rs114476330                           R120H         Damaging    Decrease     Disease    Probably damaging   5.14                
  [Q07973](uniprotkb:Q07973){#ir0095}   rs114579367                           D202H         Damaging    Decrease     Neutral    Probably damaging   3.47                
  [Q07973](uniprotkb:Q07973){#ir0100}   rs116548533                           R344H         Damaging    Decrease     Neutral    Probably damaging   3.88                
  [Q07973](uniprotkb:Q07973){#ir0105}   rs139763321                           L148P         Damaging    Decrease     Disease    Probably damaging   4.67                
  [Q07973](uniprotkb:Q07973){#ir0110}   rs140189382                           Y407N         Damaging    Decrease     Disease    Probably damaging   3.46                
  [Q07973](uniprotkb:Q07973){#ir0115}   rs141152573                           R439H         Damaging    Decrease     Disease    Probably damaging   3.26                
  [Q07973](uniprotkb:Q07973){#ir0120}   rs143934667                           R396Q         Damaging    Decrease     Disease    Probably damaging   3.53                
  [Q07973](uniprotkb:Q07973){#ir0125}   rs146980218                           R439Q         Damaging    Decrease     Disease    Probably damaging   3.24                

###### 

Solvent accessibility of the wild type and mutant type of FGF23, VDR, CYP24A1 proteins.

Table 3

  Gene      Mutation                                                              Exposed to buried                             Buried to exposed
  --------- --------------------------------------------------------------------- --------------------------------------------- ----------------------
  FGF23     M96T                                                                  36W, 40I, 50S, 108F, 122N, 166L, 167I, 168H   48R, 68T, 170N, 171T
  R160Q     36W, 49N, 81G, 167I                                                   154Y, 160R, 170N,                             
  S71G      33G, 81G, 166L, 167I, 168H                                            48R, 68T, 170N, 171T                          
  S129F     36W, 40I, 50S, 108F, 122N, 130P, 131Q, 133H, 143R, 166L, 167I, 168H   30P, 48R, 68T, 154Y, 169F, 170N               
  VDR       E329K                                                                 142T, 239Q, 284M, 300V, 341P                  312P, 376S
  I314S     142T, 239Q, 280T, 300V, 385Q, 389D                                    145P                                          
  I367M     142T, 239Q, 385Q, 389D                                                145P, 290N, 306S                              
  L230V     142T, 143Y, 389D                                                      290N, 303A                                    
  R154K     389D, 142T, 341P, 389D                                                415T                                          
  R274L     239Q, 264K, 284M, 341P, 389D                                          145P, 290N, 303A, 314I, 376S                  
  R358H     142T, 239Q, 389D                                                      145P, 285S, 290N, 295Y, 306S                  
  R391C     239Q, 385Q, 389D                                                      145P, 295Y, 376S, 410C, 419L                  
  CYP24A1   D202H                                                                 264N                                          143E
  E322K     232G                                                                  87V, 353L                                     
  L148P     140Y, 143E, 353L                                                      136A, 264N                                    
  L409S     262S, 264N                                                            --                                            
  R120H     264N                                                                  353L                                          
  R159Q     176M, 232G, 264N                                                      140Y                                          
  R344H     193L, 232G, 264N                                                      140Y, 353L                                    
  R396K     264N, 300D                                                            140Y, 353L                                    
  R396Q     129L, 300D                                                            353L                                          
  R439H     136A, 232G                                                            140Y, 353L                                    

###### 

Predicted value of pH of optimum stability, pI of folding and unfolding and free energy for wild type and selected mutant type genes.

Table 4

  Protein   Amino acid change   pH of optimum stability   pI value folded   pI value unfolded   Free energy (kcal/mol)
  --------- ------------------- ------------------------- ----------------- ------------------- ------------------------
  FGF23     WT                  9.6                       9.32              9.42                0.7
  M96T      9.6                 9.32                      9.42              0.6                 
  160Q      9.6                 8.79                      9.11              0.2                 
  S71G      9.6                 9.32                      9.42              0.6                 
  S129F     9.6                 9.32                      9.42              0.8                 
  VDR       WT                  7.9                       6.20              6.61                14.8
  E329K     8.5                 6.50                      7.03              19                  
  I314S     7.9                 6.22                      6.31              18                  
  I367M     7.9                 6.23                      6.61              18.2                
  L230V     7.9                 6.23                      6.61              18.1                
  R154K     7.9                 6.23                      6.61              21.6                
  R274L     7.8                 5.98                      6.44              13.4                
  R358H     7.9                 6.07                      6.52              17.6                
  R391C     7.8                 5.98                      6.44              17.8                
  CYP24A1   WT                  8.3                       9.01              8.86                52.3
  D202H     9.3                 9.13                      8.97              51.8                
  E322K     9.0                 9.08                      9.06              54.3                
  L148P     8.3                 9.02                      8.86              54.5                
  L409S     8.3                 9.01                      8.86              52.2                
  R120H     8.3                 8.88                      8.74              51.2                
  R159Q     8.2                 8.91                      8.74              47.4                
  R344H     8.3                 8.88                      8.74              52.0                
  R396K     8.6                 8.94                      8.86              50.5                
  R396Q     7.9                 8.94                      8.74              47.4                
  R439H     8.3                 8.87                      8.74              51.4                

WT---Wild type.
